sulfisomidine has been researched along with Toxoplasmosis, Congenital in 1 studies
Sulfisomidine: A sulfanilamide antibacterial agent.
sulfisomidine : A sulfonamide consisting of pyrimidine having methyl substituents at the 2- and 6-positions and a 4-aminobenzenesulfonamido group at the 4-position.
Toxoplasmosis, Congenital: Prenatal protozoal infection with TOXOPLASMA gondii which is associated with injury to the developing fetal nervous system. The severity of this condition is related to the stage of pregnancy during which the infection occurs; first trimester infections are associated with a greater degree of neurologic dysfunction. Clinical features include HYDROCEPHALUS; MICROCEPHALY; deafness; cerebral calcifications; SEIZURES; and psychomotor retardation. Signs of a systemic infection may also be present at birth, including fever, rash, and hepatosplenomegaly. (From Adams et al., Principles of Neurology, 6th ed, p735)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kocher, R | 1 |
| Haensch, G | 1 |
1 review available for sulfisomidine and Toxoplasmosis, Congenital
| Article | Year |
|---|---|
[New viewpoints on the treatment of toxoplasmosis].
Topics: Age Factors; Child, Preschool; Demeclocycline; Female; Humans; Infant; Leucomycins; Pregnancy; Pyrim | 1973 |